The University of Chicago Header Logo

Connection

Mary Rinella to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Mary Rinella has written about Drug Administration Schedule.
Mary Rinella
Connection Strength
0.086
Drug Administration Schedule
  1. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025 Jun 05; 392(21):2089-2099.
    View in: PubMed
    Score: 0.051
  2. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. Gastroenterology. 2020 04; 158(5):1334-1345.e5.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.